EP0543902A1
Use of metalloporphyrins to potentiate aids therapy.
Abstract
Methods and compositions for the treatment of viral infections, particularly retroviral infections such as AIDS. Such methods include administering a heme product in pharmaceutical compositions that may further include an anti-retroviral drug such as AZT with or without erythropoietin.
Term
Term ended
Projected expiry passed 25 July 2011, 15.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0337598A2 | Cites | European Patent Office (EPO) | Search report |
| WO8911277A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
7 members in 5 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 19900560191 | United States of America | – | |
| 56019190 | United States of America | A | |
| 19910735090 | United States of America | – | |
| 73509091 | United States of America | A |
Members7
| Document | Office | Kind | |
|---|---|---|---|
| CA2088593A1 | Canada | A1 | |
| WO9202242A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8410491A | Australia | A | |
| EP0543902A1This record | European Patent Office (EPO) | A1 | |
| JPH05504774A | Japan | A | |
| EP0543902A4 | European Patent Office (EPO) | A4 | |
| AU645131B2 | Australia | B2 |
12 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| First examination report despatched17Q | 17Q | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Designated contracting statesAK | AK | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 0543902
- Application
- 919150680
Titles3
- English
- USE OF METALLOPORPHYRINS TO POTENTIATE AIDS THERAPY
- French
- UTILISATION DE METALLOPORPHYRINES POUR POTENTIALISER LA THERAPIE CONTRE LE SIDA
- German
- DIE VERWENDUNG VON METALLPORPHYRINEN UM DIE AIDS-THERAPIE ZUM ENTFALTEN ZU BRINGEN
Classification
- CPC, 7
- A61K31/70
- A61K31/555
- A61K38/1816
- A61K38/41
- A61P31/12
- A61P31/18
- A61P43/00
- IPC, 8
- A61K31 40
- A61K31 505
- A61K31 555
- A61K38 18
- A61K38 41
- A61P31 12
- A61P31 18
- A61P43 00
Designated states14
- Contracting states, 14
- Austria
- Belgium
- Switzerland
- Germany
- Denmark
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden